Patents by Inventor Tsai-Ling LIAO

Tsai-Ling LIAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11047012
    Abstract: The present invention discloses a new biomarker miR-134, miR-223, or IL-18, which is positively correlated with AOSD and activities thereof. By detecting the expression level of at least one biomarker in a sample, an effect of detecting the risk and prognosis of a sample provider suffering from a disease is achieved.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: June 29, 2021
    Assignee: TAICHUNG VETERANS GENERAL HOSPITAL
    Inventors: Tsai-Ling Liao, Der-Yuan Chen
  • Publication number: 20190352701
    Abstract: The present invention discloses a method for evaluating the status of latent tuberculosis infection, a method for evaluating the effect of a treatment therefor, and a treatment therefor. In the method for evaluating the status of latent tuberculosis infection, and the method for evaluating the effect of a treatment therefor, the expression level (s) of miR-889 and/or TWEAK are/is detected and used as a basis for analysis.
    Type: Application
    Filed: September 27, 2018
    Publication date: November 21, 2019
    Inventors: Tsai-Ling Liao, Der-Yuan Chen
  • Publication number: 20190345555
    Abstract: The present invention discloses a new biomarker miR-134, miR-223, or IL-18, which is positively correlated with AOSD and activities thereof. By detecting the expression level of at least one biomarker in a sample, an effect of detecting the risk and prognosis of a sample provider suffering from a disease is achieved.
    Type: Application
    Filed: June 21, 2018
    Publication date: November 14, 2019
    Inventors: Tsai-Ling LIAO, Der-Yuan CHEN